{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:02:54Z","timestamp":1781712174464,"version":"3.54.5"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AIIMS Intramural","award":["F.8-539\/A-539\/2017\/RS"],"award-info":[{"award-number":["F.8-539\/A-539\/2017\/RS"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Helicobacter pylori infection has been associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD). This study was done to evaluate the effect of H. pylori-eradication therapy (HPET) in patients with NAFLD compared to standard management therapy (SMT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighty NAFLD patients with H. pylori co-infection were randomized into SMT (diet and exercise, n\u2009=\u200936) and HPET (SMT plus amoxicillin, clarithromycin, and pantoprazole, n\u2009=\u200944) groups. The controlled attenuation parameter (CAP), anthropometric parameters, liver enzymes, lipid profile, and glycemic parameters including homeostasis model assessment-insulin resistance (HOMA-IR) were measured and compared between two groups at the baseline and 24\u2009weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sixty-four participants (SMT group [n\u2009=\u200928] and HPET group [n\u2009=\u200936]) were included in a modified intention-to-treat analysis. Both the SMT group and the HPET group had a significant reduction in CAP scores at 24\u2009weeks (P\u2009=\u20090.002 and P\u2009&amp;lt;\u20090.001, respectively), but the change between the groups was insignificant (P\u2009=\u20090.213). Successful eradication of H. pylori occurred in 68% of the HPET group and led to greater improvement in HOMA-IR at 24\u2009weeks compared to SMT or non-responder patients (P\u2009=\u20090.007). The liver enzymes reduced significantly at 24\u2009weeks in both groups, but the changes between the groups were similar. The lipid parameters remained unchanged within the groups and between the groups at 24\u2009weeks. A significant increase in the levels of reduced glutathione was noted in the HPET group, but the change between the two groups was not statistically different.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HPET was found to be comparable to SMT alone in reducing hepatic steatosis and liver enzymes at 24\u2009weeks in NAFLD patients. However, successful eradication of H. pylori led to greater improvement in HOMA-IR (Trial registration CTRI\/2017\/05\/008608).<\/jats:p><\/jats:sec>","DOI":"10.1093\/gastro\/goz058","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T20:10:02Z","timestamp":1574367002000},"page":"104-110","source":"Crossref","is-referenced-by-count":19,"title":["Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized\u2013controlled pilot study"],"prefix":"10.1093","volume":"8","author":[{"given":"Vikas","family":"Maharshi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay L","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Datt","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasenjit","family":"Das","sequence":"first","affiliation":[{"name":"Department of Pathology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Yadav","sequence":"first","affiliation":[{"name":"Department of Pathology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baibaswata","family":"Nayak","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-4865","authenticated-orcid":false,"given":"Ramesh","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"2020053015195513900_goz058-B1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"2020053015195513900_goz058-B2","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"2020053015195513900_goz058-B3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab Clin Exp"},{"key":"2020053015195513900_goz058-B4","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.3748\/wjg.v19.i41.7024","article-title":"Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease","volume":"19","author":"Li","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2020053015195513900_goz058-B5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4103\/2230-8210.139235","article-title":"Association of Helicobacter pylori infection with type 2 diabetes","volume":"18","author":"Bajaj","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"2020053015195513900_goz058-B6","doi-asserted-by":"crossref","first-page":"37.","DOI":"10.1186\/1471-230X-11-37","article-title":"The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin","volume":"11","author":"Francois","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"2020053015195513900_goz058-B7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"},{"key":"2020053015195513900_goz058-B8","doi-asserted-by":"crossref","first-page":"26.","DOI":"10.1186\/1743-7075-7-26","article-title":"Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007)","volume":"7","author":"Esteghamati","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"2020053015195513900_goz058-B9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.2040-1124.2010.00041.x","article-title":"Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance","volume":"1","author":"Onishi","year":"2010","journal-title":"J Diabetes Investig"},{"key":"2020053015195513900_goz058-B10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jceh.2018.02.010","article-title":"Controlled attenuation parameter for assessment of hepatic steatosis in Indian patients","volume":"9","author":"Rout","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"2020053015195513900_goz058-B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.soard.2017.09.005","article-title":"Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients","volume":"14","author":"Garg","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"2020053015195513900_goz058-B12","first-page":"549","article-title":"Helicobacter pylori infection in India from a Western perspective","volume":"136","author":"Thirumurthi","year":"2012","journal-title":"Indian J Med Res"},{"key":"2020053015195513900_goz058-B13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00054-05","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"19","author":"Kusters","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"2020053015195513900_goz058-B14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MEG.0b013e3283590c10","article-title":"Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study","volume":"25","author":"Do\u011fan","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2020053015195513900_goz058-B15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fmicb.2017.00743","article-title":"The possible role of Helicobacter pylori infection in non-alcoholic fatty liver disease","volume":"8","author":"Cheng","year":"2017","journal-title":"Front Microbiol"},{"key":"2020053015195513900_goz058-B16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s10620-005-3012-z","article-title":"The effect of Helicobacter pylori on insulin resistance","volume":"50","author":"Aydemir","year":"2005","journal-title":"Dig Dis Sci"},{"key":"2020053015195513900_goz058-B17","doi-asserted-by":"crossref","first-page":"e14679.","DOI":"10.5812\/hepatmon.14679","article-title":"The effect of Helicobacter pylori eradication on liver fat content in subjects with non-alcoholic fatty liver disease: a randomized open-label clinical trial","volume":"13","author":"Jamali","year":"2013","journal-title":"Hepat Mon"},{"key":"2020053015195513900_goz058-B18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0004-28032014000300017","article-title":"Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study","volume":"51","author":"Polyzos","year":"2014","journal-title":"Arq Gastroenterol"},{"key":"2020053015195513900_goz058-B19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/2\/104\/33327388\/goz058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/gastro\/article-pdf\/8\/2\/104\/33327388\/goz058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:08:20Z","timestamp":1665076100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/8\/2\/104\/5640491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,25]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/gastro\/goz058","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2019,11,25]]}}}